Switch to:
Cardiovascular Systems Inc (NAS:CSII)
EV/EBITDA
-14.20 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Cardiovascular Systems Inc's enterprise value is $740.5 Mil. Cardiovascular Systems Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2016 was $-52.2 Mil. Therefore, Cardiovascular Systems Inc's EV/EBITDA ratio for today is -14.20.

CSII' s EV/EBITDA Range Over the Past 10 Years
Min: -37.9   Max: 6.7
Current: -14.2

-37.9
6.7

During the past 13 years, the highest EV/EBITDA Ratio of Cardiovascular Systems Inc was 6.70. The lowest was -37.90. And the median was -10.90.

CSII's EV/EBITDA is ranked lower than
99.99% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 18.25 vs. CSII: -14.20 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Cardiovascular Systems Inc's stock price is $24.54. Cardiovascular Systems Inc's earnings per share for the trailing twelve months (TTM) ended in Jun. 2016 was $-1.72. Therefore, Cardiovascular Systems Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Cardiovascular Systems Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=740.468/-52.16
=-14.20

Cardiovascular Systems Inc's current Enterprise Value is $740.5 Mil.
Cardiovascular Systems Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2016 was -12.263 (Sep. 2015 ) + -14.162 (Dec. 2015 ) + -21.737 (Mar. 2016 ) + -3.998 (Jun. 2016 ) = $-52.2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Cardiovascular Systems Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=24.54/-1.72
=

Cardiovascular Systems Inc's share price for today is $24.54.
Cardiovascular Systems Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2016 was -0.41 (Sep. 2015 ) + -0.47 (Dec. 2015 ) + -0.69 (Mar. 2016 ) + -0.15 (Jun. 2016 ) = $-1.72.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Cardiovascular Systems Inc Annual Data

Dec07Dec08Jun09Jun10Jun11Jun12Jun13Jun14Jun15Jun16
ev2ebitda -1.390.48-4.07-2.49-26.51-12.81-21.25-26.28-25.00-10.34

Cardiovascular Systems Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
ev2ebitda -27.95-26.28-18.91-27.99-36.83-25.00-12.51-9.69-4.92-10.34
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK